Association of anti-GM2 antibodies in Guillain-Barré syndrome with acute cytomegalovirus infection

J Neuroimmunol. 1996 Aug;68(1-2):19-26. doi: 10.1016/0165-5728(96)00059-8.

Abstract

We examined serum anti-cytomegalovirus (CMV) and anti-ganglioside antibodies by ELISA in 51 patients with Guillain-Barré syndrome (GBS), and titers were compared with those from 47 normal and 74 disease controls. Three GBS patients with IgM anti-CMV antibodies had high titers of IgM and IgG anti-GM2 antibodies. The other GBS patients without IgM anti-CMV antibodies, and the normal and disease controls except one of 6 non-GBS patients with acute CMV infections had no anti-GM2 antibodies. The titers of anti-GM2 antibodies decreased on absorption with CMV-infected cells. These findings suggest that anti-GM2 antibodies are associated with acute CMV infections in GBS patients.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Viral / analysis
  • Antibody Specificity
  • Carbohydrate Sequence
  • Chromatography, Thin Layer
  • Cytomegalovirus / immunology
  • Cytomegalovirus Infections / complications
  • Cytomegalovirus Infections / immunology*
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • G(M2) Ganglioside / immunology*
  • Humans
  • Immunoblotting
  • Immunoglobulin G / blood
  • Immunoglobulin M / blood
  • Male
  • Middle Aged
  • Molecular Sequence Data
  • Polyradiculoneuropathy / complications
  • Polyradiculoneuropathy / immunology*
  • Polyradiculoneuropathy / virology*

Substances

  • Antibodies, Viral
  • Immunoglobulin G
  • Immunoglobulin M
  • G(M2) Ganglioside